thalidomide has been researched along with Cardiomyopathies in 6 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-dose melphalan (HDM) followed by autologous stem cell transplant (ASCT) for light chain amyloidosis (AL) was performed in 31 patients at Oregon Health and Science University between 2005 and 2012." | 7.80 | Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study. ( Abar, F; Dibb, J; Dibb, W; Frires, R; Heitner, SB; Kovacsovics, T; Maziarz, RT; Meyers, G; Perez-Avraham, G; Scott, EC; Smith, SD; Stentz, A, 2014) |
| "High-dose melphalan (HDM) followed by autologous stem cell transplant (ASCT) for light chain amyloidosis (AL) was performed in 31 patients at Oregon Health and Science University between 2005 and 2012." | 3.80 | Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study. ( Abar, F; Dibb, J; Dibb, W; Frires, R; Heitner, SB; Kovacsovics, T; Maziarz, RT; Meyers, G; Perez-Avraham, G; Scott, EC; Smith, SD; Stentz, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Khandkar, C | 1 |
| Vaidya, K | 1 |
| Penglase, R | 1 |
| Cai, K | 1 |
| Shin, JS | 1 |
| Hunyor, I | 1 |
| Keech, A | 1 |
| McGill, N | 1 |
| Scott, EC | 1 |
| Heitner, SB | 1 |
| Dibb, W | 1 |
| Meyers, G | 1 |
| Smith, SD | 1 |
| Abar, F | 1 |
| Kovacsovics, T | 1 |
| Perez-Avraham, G | 1 |
| Stentz, A | 1 |
| Frires, R | 1 |
| Dibb, J | 1 |
| Maziarz, RT | 1 |
| De Lazzari, M | 1 |
| Fedrigo, M | 1 |
| Migliore, F | 1 |
| Cianci, A | 1 |
| Cacciavillani, L | 1 |
| Tarantini, G | 1 |
| Giorgi, B | 1 |
| Iliceto, S | 1 |
| Thiene, G | 1 |
| Valente, M | 1 |
| Angelini, A | 1 |
| Adami, F | 1 |
| Perazzolo Marra, M | 1 |
| Chan, LL | 1 |
| Lim, CP | 1 |
| Lim, CH | 1 |
| Tan, TE | 1 |
| Sim, D | 1 |
| Sivathasan, C | 1 |
| Desport, E | 1 |
| Moumas, E | 1 |
| Abraham, J | 1 |
| Delbès, S | 1 |
| Lacotte-Thierry, L | 1 |
| Touchard, G | 1 |
| Fermand, JP | 1 |
| Bridoux, F | 1 |
| Jaccard, A | 1 |
| Homburger, F | 1 |
| Bajusz, E | 1 |
1 review available for thalidomide and Cardiomyopathies
| Article | Year |
|---|---|
[Current treatment of AL amyloidosis].
Topics: Amyloid; Amyloidosis; Biomarkers; Boronic Acids; Bortezomib; Cardiomyopathies; Consensus Development | 2011 |
5 other studies available for thalidomide and Cardiomyopathies
| Article | Year |
|---|---|
Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema.
Topics: Adult; Cardiomyopathies; Female; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; P | 2020 |
Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study.
Topics: Adult; Aged; Amyloidogenic Proteins; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bo | 2014 |
Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance Pattern.
Topics: Bortezomib; Cardiomyopathies; Combined Modality Therapy; Defibrillators, Implantable; Dexamethasone; | 2016 |
Novel Use of Thalidomide in Recurrent Gastrointestinal Tract Bleeding in Patients with Left Ventricular Assist Devices: A Case Series.
Topics: Aged; Angiogenesis Inhibitors; Cardiomyopathies; Dose-Response Relationship, Drug; Gastrointestinal | 2017 |
New models of human disease in Syrian hamsters.
Topics: Adenoma; Adrenal Gland Neoplasms; Animals; Cardiomyopathies; Cricetinae; Cyclamates; Disease Models, | 1970 |